AMHR2

OMIMHGNC

Synonym(s): MISR2, MISRII

Locus: 12q13.13

Protein: Anti-Muellerian hormone type-2 receptor

 

Disorders

Tests

Test Type
Molecular (9)
Multi-Gene Panel (3)
Multi-Method Panel (4)
Test Method
Del/Dup (CNV) (3)
Mutation Scanning of Select Exons (1)
Sequencing, Capillary (Sanger) (5)
Genotyping (Microarray, Beads, etc.) (1)
Sequencing, Next Gen (4)
Prenatal/Carrier
Prenatal (3)
Carrier (6)
Lab Location
Spain(2)
Portugal(1)
USA(3)
Finland(1)
Austria(1)
Germany(1)
 
TAT: 6-7 weeks
price: contact lab
Detection of mutation c.6331del27 in the AMHR2 gene
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Mutation Scanning of Select Exons 
Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain
Persistent Mullerian Duct Syndrome Type II , Sequencing AMHR2 Gene
method(s): ◦ Sequencing, Capillary (Sanger) 
Reference Laboratory Genetics - Hospitalet de Llobregat, Spain
TAT: 7-10 days
price: contact lab
Persistent Mullerian Duct Syndrome: Type II
method(s): ◦ Genotyping (Microarray, Beads, etc.) 
Recombine - Livingston, NJ, USA
Persistent Mullerian duct syndrome type II (sequence analysis of AMHR2 gene)
method(s): ◦ Sequencing, Capillary (Sanger) 
CGC Genetics - Porto, Portugal
TAT: 8-9 weeks
price: contact lab
46,XY Disorders of Sex Development/Complete Gonadal Dysgenesis Sequencing Panel
method(s): ◦ Sequencing, Next Gen 
University of Chicago, Genetic Services Laboratory - Chicago, IL, USA
TAT: 4-5 Weeks
price: contact lab
AMHR2
method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) 
Fulgent Diagnostics - Temple City, CA, USA
TAT: 3-4 weeks
price: contact lab
Abnormal Genitalia/ Disorders of Sex Development Panel
method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen 
Blueprint Genetics - Helsinki, Finland
Persistent Mullerian duct syndrome (Mùˆller-Gang-Persistenzsyndrom)
method(s): ◦ Sequencing, Next Gen 
Praxis fuer Humangenetik Wien - Vienna, Austria
TAT: ~2 weeks
price: contact lab
Persistent Mullerian duct syndrome type 2
method(s): ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) 
Centogene AG, Rare Disease Company - Rostock, Germany